Phreesia Inc. (PHR) Acquires Insignia Health
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/20/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo Downgrades Netflix (NFLX) to Underweight on Engagement Risks, 'We see tougher choices ahead'
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
Phreesia Inc. (PHR) PT Lowered to $54 at Citi
December 10, 2021 6:37 AM ESTCiti analyst Daniel Grosslight lowered the price target on Phreesia Inc. (NYSE: PHR) to $54.00 (from $72.00) while maintaining a Neutral rating.... More
Pre-Open Stock Movers 12/09: (IINN) (AVCT) (RH) Higher; (RETA) (RLMD) (GME) Lower (more...)
December 9, 2021 9:29 AM ESTPre-Open Movers:
Inspira Technologies OXY B.H.N. Ltd. (Nasdaq: IINN) 113% HIGHER; signed an exclusive summary distribution agreement with Innovimed Sp. z o.o ("Innovimed"), a master distributor specializing in state-of-the-art medical solutions in Eastern Europe, Middle East and Africa. The Innovimed leadership team, have decades of experience with sales, marketing and distribution with medical devices in global healthcare industry companies including Baxter (AG).
Reata Pharmaceuticals, Inc. (Nasdaq:... More
Phreesia Inc. (PHR) PT Lowered to $65 at Needham & Company, But 'Buyers on Weakness'
December 9, 2021 7:07 AM ESTNeedham & Company analyst Ryan MacDonald lowered the price target on Phreesia Inc. (NYSE: PHR) to $65.00 (from $81.00) while maintaining a Buy rating.
The analyst commented, "We reiterate our Buy rating, while lowering our PT to $65, following the company's 3QF22 results in which revenue... More
Phreesia Inc. (PHR) PT Lowered to $51 at RBC Capital
December 9, 2021 7:01 AM ESTRBC Capital analyst Sean Dodge lowered the price target on Phreesia Inc. (NYSE: PHR) to $51.00 (from $60.00) while maintaining a Sector Perform rating.... More
